Literature DB >> 10749687

Involvement of proline-rich tyrosine kinase 2 in platelet activation: tyrosine phosphorylation mostly dependent on alphaIIbbeta3 integrin and protein kinase C, translocation to the cytoskeleton and association with Shc through Grb2.

T Ohmori1, Y Yatomi, N Asazuma, K Satoh, Y Ozaki.   

Abstract

Proline-rich tyrosine kinase 2 (Pyk2) (also known as RAFTK, CAKbeta or CADTK) has been identified as a member of the focal adhesion kinase (FAK) family of protein-tyrosine kinases and it has been suggested that the mode of Pyk2 activation is distinct from that of FAK. In the present study we investigated the mode of Pyk2 activation in human platelets. When platelets were stimulated with thrombin, Pyk2, as well as FAK, was markedly tyrosine-phosphorylated, in a manner mostly dependent on alphaIIbbeta3 integrin-mediated aggregation. The residual Pyk2 tyrosine phosphorylation observed in the absence of platelet aggregation was completely abolished by pretreatment with BAPTA/AM [bis-(o-aminophenoxy)ethane-N,N,N',N'-tetra-acetic acid acetoxymethyl ester]. The Pyk2 phosphorylation was inhibited by protein kinase C (PKC) inhibitors at concentrations that inhibited platelet aggregation. In contrast, direct activation of PKC with the active phorbol ester PMA induced the tyrosine phosphorylation of Pyk2 and FAK but only when platelets were fully aggregated with the exogenous addition of fibrinogen (the ligand for alphaIIbbeta3 integrin). Furthermore, PMA-induced Pyk2 (and FAK) tyrosine phosphorylation was also observed when platelets adhered to immobilized fibrinogen. The activation of the von Willebrand factor (vWF)--glycoprotein Ib pathway with botrocetin together with vWF failed to induce Pyk2 (and FAK) tyrosine phosphorylation. Most Pyk2 and FAK was present in the cytosol and membrane skeleton fractions in unstimulated platelets. When platelets were stimulated with thrombin, both Pyk2 and FAK were translocated to the cytoskeleton in an aggregation-dependent manner. In immunoprecipitation studies, Pyk2, as well as FAK, seemed to associate with Shc through Grb2. With the use of glutathione S-transferase fusion proteins containing Shc-SH2, Grb2-SH2, and Grb2 N-terminal and C-terminal SH3 domains, it was implied that the proline-rich region of Pyk2 (and FAK) binds to the N-terminal SH3 domain of Grb2 and that the phosphotyrosine residue of Shc binds to the SH2 domain of Grb2. Although Pyk2 and FAK have been reported to be differentially regulated in many cell types, our results suggest that, in human platelets, the mode of Pyk2 activation is mostly similar to that of FAK, in terms of alphaIIbbeta3 integrin-dependent and PKC-dependent tyrosine phosphorylation. Furthermore, Pyk2, as well as FAK, might have one or more important roles in post-aggregation tyrosine phosphorylation events, in association with the cytoskeleton and through interaction with adapter proteins including Grb2 and Shc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10749687      PMCID: PMC1220990          DOI: 10.1042/0264-6021:3470561

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  52 in total

1.  Characterization of RAFTK, a novel focal adhesion kinase, and its integrin-dependent phosphorylation and activation in megakaryocytes.

Authors:  J Li; H Avraham; R A Rogers; S Raja; S Avraham
Journal:  Blood       Date:  1996-07-15       Impact factor: 22.113

Review 2.  The molecular heterogeneity of protein kinase C and its implications for cellular regulation.

Authors:  Y Nishizuka
Journal:  Nature       Date:  1988-08-25       Impact factor: 49.962

Review 3.  Biochemistry of alpha granule proteins.

Authors:  J C Holt; S Niewiarowski
Journal:  Semin Hematol       Date:  1985-04       Impact factor: 3.851

Review 4.  The platelet membrane glycoprotein IIb-IIIa complex.

Authors:  D R Phillips; I F Charo; L V Parise; L A Fitzgerald
Journal:  Blood       Date:  1988-04       Impact factor: 22.113

5.  Potent selective inhibitors of protein kinase C.

Authors:  P D Davis; C H Hill; E Keech; G Lawton; J S Nixon; A D Sedgwick; J Wadsworth; D Westmacott; S E Wilkinson
Journal:  FEBS Lett       Date:  1989-12-18       Impact factor: 4.124

6.  p130Cas, a substrate associated with v-Src and v-Crk, localizes to focal adhesions and binds to focal adhesion kinase.

Authors:  M T Harte; J D Hildebrand; M R Burnham; A H Bouton; J T Parsons
Journal:  J Biol Chem       Date:  1996-06-07       Impact factor: 5.157

7.  Induction of the fibrinogen receptor on human platelets by intracellular mediators.

Authors:  S J Shattil; L F Brass
Journal:  J Biol Chem       Date:  1987-01-25       Impact factor: 5.157

8.  Anti-CD9 monoclonal antibody activates p72syk in human platelets.

Authors:  Y Ozaki; K Satoh; K Kuroda; R Qi; Y Yatomi; S Yanagi; K Sada; H Yamamura; M Yanabu; S Nomura
Journal:  J Biol Chem       Date:  1995-06-23       Impact factor: 5.157

9.  Integrin-mediated signal transduction linked to Ras pathway by GRB2 binding to focal adhesion kinase.

Authors:  D D Schlaepfer; S K Hanks; T Hunter; P van der Geer
Journal:  Nature       Date:  1994 Dec 22-29       Impact factor: 49.962

10.  Synergistic functions of protein phosphorylation and calcium mobilization in platelet activation.

Authors:  K Kaibuchi; Y Takai; M Sawamura; M Hoshijima; T Fujikura; Y Nishizuka
Journal:  J Biol Chem       Date:  1983-06-10       Impact factor: 5.157

View more
  10 in total

1.  Megakaryocytes regulate expression of Pyk2 isoforms and caspase-mediated cleavage of actin in osteoblasts.

Authors:  Melissa A Kacena; Pierre P Eleniste; Ying-Hua Cheng; Su Huang; Mahesh Shivanna; Tomas E Meijome; Lindsey D Mayo; Angela Bruzzaniti
Journal:  J Biol Chem       Date:  2012-03-23       Impact factor: 5.157

2.  Gq pathway regulates proximal C-type lectin-like receptor-2 (CLEC-2) signaling in platelets.

Authors:  Rachit Badolia; Vaishali Inamdar; Bhanu Kanth Manne; Carol Dangelmaier; Johannes A Eble; Satya P Kunapuli
Journal:  J Biol Chem       Date:  2017-07-13       Impact factor: 5.157

3.  Involvement of Hic-5 in platelet activation: integrin alphaIIbbeta3-dependent tyrosine phosphorylation and association with proline-rich tyrosine kinase 2.

Authors:  M Osada; T Ohmori; Y Yatomi; K Satoh; S Hosogaya; Y Ozaki
Journal:  Biochem J       Date:  2001-05-01       Impact factor: 3.857

Review 4.  Factor XIII is a key molecule at the intersection of coagulation and fibrinolysis as well as inflammation and infection control.

Authors:  Akitada Ichinose
Journal:  Int J Hematol       Date:  2012-04-05       Impact factor: 2.490

5.  Differential effect of the inhibition of Grb2-SH3 interactions in platelet activation induced by thrombin and by Fc receptor engagement.

Authors:  Abdelhafid Saci; Wang-Qing Liu; Michel Vidal; Christiane Garbay; Francine Rendu; Christilla Bachelot-Loza
Journal:  Biochem J       Date:  2002-05-01       Impact factor: 3.857

6.  Immune versus thrombotic stimulation of platelets differentially regulates signalling pathways, intracellular protein-protein interactions, and alpha-granule release.

Authors:  Sybille Rex; Lea M Beaulieu; David H Perlman; Olga Vitseva; Price S Blair; Mark E McComb; Catherine E Costello; Jane E Freedman
Journal:  Thromb Haemost       Date:  2009-07       Impact factor: 5.249

7.  Distinct role of Pyk2 in mediating thromboxane generation downstream of both G12/13 and integrin αIIbβ3 in platelets.

Authors:  Soochong Kim; Lina Cipolla; Gianni Guidetti; Mitsuhiko Okigaki; Jianguo Jin; Mauro Torti; Satya P Kunapuli
Journal:  J Biol Chem       Date:  2013-05-02       Impact factor: 5.157

8.  Pyk2 and Megakaryocytes Regulate Osteoblast Differentiation and Migration Via Distinct and Overlapping Mechanisms.

Authors:  Pierre P Eleniste; Vruti Patel; Sumana Posritong; Odette Zero; Heather Largura; Ying-Hua Cheng; Evan R Himes; Matthew Hamilton; Jenna T B Ekwealor; Melissa A Kacena; Angela Bruzzaniti
Journal:  J Cell Biochem       Date:  2015-12-10       Impact factor: 4.429

9.  Role of focal adhesion tyrosine kinases in GPVI-dependent platelet activation and reactive oxygen species formation.

Authors:  Naadiya Carrim; Tony G Walsh; Alessandra Consonni; Mauro Torti; Michael C Berndt; Pat Metharom
Journal:  PLoS One       Date:  2014-11-21       Impact factor: 3.240

Review 10.  Tannins as Hemostasis Modulators.

Authors:  Natalia Marcińczyk; Anna Gromotowicz-Popławska; Michał Tomczyk; Ewa Chabielska
Journal:  Front Pharmacol       Date:  2022-01-13       Impact factor: 5.810

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.